ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Role of Innate Immunity in Regulating Host Responses to Ischemia and Reperfusion and Allograft Rejection Injury in Vascularized Composite Allotransplantation

S. Han1, X. Lai2, J. Wang1, L. VanOsdol3, C. Chen1, J. Mathew1, J. R. Leventhal4, Z. Zhang5

1Northwestern University, Chicago, IL, 2Comprehensive Transplant Center, Microsurgery Core, Northwestern University, Chicago, IL, 3Comprehensive Transplant Center, Northwestern University, Chicago, IL, 4Surgery, Northwestern Medicine, Chicago, IL, 5Northwestern University Transplant Surgery, Chicago, IL

Meeting: 2022 American Transplant Congress

Abstract number: 461

Keywords: Rejection, T cell graft infiltration

Topic: Basic & Clinical Science » Basic & Clinical Science » 20 - VCA

Session Information

Session Name: VCA

Session Type: Rapid Fire Oral Abstract

Date: Tuesday, June 7, 2022

Session Time: 3:30pm-5:00pm

 Presentation Time: 4:40pm-4:50pm

Location: Hynes Room 313

*Purpose: Vascularized composite tissue allotransplantation (VCA) ‘s wide application has been impeded by deleterious side-effect of current immunosuppressive regimens. This study is aimed to determine whether targeting Myeloid differentiation primary response 88 (MyD88) dependent innate immune response reduces VCA associated ischemia and reperfusion (I/R) response and delay VCA graft rejection in a mouse hind-limb transplantation model.

*Methods: Right hind-limbs from B6 (isografts) or BALB/c (allografts) mice were orthotopically transplanted to either amputated WT B6 mice or mice deficient of Myd88 alone (Myd88-/-) or Myd88 and TRIF (double knockout mice) on B6 background. Graft rejection, survivals, post-transplant systemic responses were monitored and the RNA expression of signal pathway downstream inflammatory factors in the graft skin and muscle were performed at 7 days after VCA. Phenotypic analysis of infiltrating cells in graft muscle were performed using Flow-Cytometry. Additionally, graft histology was examined by H&E staining.

*Results: Abrogating Myd88 in recipient significantly reduced immediate post-transplant local and systemic inflammation, as manifested by edema and BUN levels, in both Myd88-/- or double ko hind-limb isografts and allografts. Moreover, recipient MyD88 deficiency significantly delayed rejection process in the full MHC-mismatched VCA allografts (from 7 days to 15 days post-transplant). MyD88-/- recipients have significantly reduced graft-Infiltrating cells on day 7 after VCA. Specifically, phenotypic analysis showed marked reduction of neutrophils, macrophages and CD8 T cells in the Myd88-/- allograft, compared with Myd88+/+ allograft, which accompanied by downregulated expression of proinflammatory cytokines (TNFa, IL-6, IL-1) in the skin and skeletal muscles of Myd88 ko limb allografts. In stark contrast, there was a significant increase in the frequency of regulatory T cells (CD4+CD25+Foxp3+) homing in the limb Myd88-/- allografts . Interestingly, abrogating Myd88 significantly upregulated expression of amphiregulin a ligand of the epidermal growth factor receptor in the muscle of Myd88-/- allografts.

*Conclusions: Inhibition of innate immunity by genetic depletion of MyD88 in recipients significantly delayed limb allografts rejection and promoted generation and accumulation of Tregs in the limb graft limb. Our results for the first time revealed that Myd88 deletion upregulated expression of muscular amphiregulin, a tissue factor associated with enhancing Treg function and tissue repair.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Han S, Lai X, Wang J, VanOsdol L, Chen C, Mathew J, Leventhal JR, Zhang Z. Role of Innate Immunity in Regulating Host Responses to Ischemia and Reperfusion and Allograft Rejection Injury in Vascularized Composite Allotransplantation [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/role-of-innate-immunity-in-regulating-host-responses-to-ischemia-and-reperfusion-and-allograft-rejection-injury-in-vascularized-composite-allotransplantation/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences